These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13891908)

  • 41. [The glutamic-oxalacetic transaminase activity of the cerebrospinal fluid of children with poliomyelitis].
    MARANDOLA G; IANNIRUBERTO A
    Rass Neuropsichiatr; 1962; 16():85-90. PubMed ID: 14469539
    [No Abstract]   [Full Text] [Related]  

  • 42. [Introduction and application of CSF cytology for diagnosis and treatment of central nervous system diseases].
    Su XC; Zhao G; Yang YN; Deng YC
    Acta Neurol Taiwan; 2006 Jun; 15(2):143-8. PubMed ID: 16871902
    [No Abstract]   [Full Text] [Related]  

  • 43. Cerebrospinal fluid cytology in canine neurologic disease.
    Vandevelde M; Spano JS
    Am J Vet Res; 1977 Nov; 38(11):1827-32. PubMed ID: 579291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of transaminase activity in the cerebrospinal fluid in paralytic poliomyelitis. Preliminary report.
    ABBASSY AS; ABOULWAFA MH
    J Pediatr; 1961 Jul; 59():60-7. PubMed ID: 13680912
    [No Abstract]   [Full Text] [Related]  

  • 45. [Transaminase activity (GOT and GPT) in blood serum and cerebrospinal fluid in neurological diseases].
    PREC A; KRYSA I; MAYER J
    Psychiatr Neurol Med Psychol (Leipz); 1961 Nov; 13():406-11. PubMed ID: 14488561
    [No Abstract]   [Full Text] [Related]  

  • 46. [Diagnostic value of quantitative and qualitative variations in cerebrospinal fluid proteins].
    Olischer RM
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):449-64. PubMed ID: 73198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [First results of the determination of transaminase activity of cerebrospinal fluid in patients with neurological diseases].
    FIESCHI C; SORIANI S
    Boll Soc Ital Biol Sper; 1957; 33(10-11):1445-8. PubMed ID: 13546309
    [No Abstract]   [Full Text] [Related]  

  • 48. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid transaminase and lactic dehydrogenase activities in neurologic disease.
    GREEN JB; OLDEWURTEL HA; O'DOHERTY DS; FORSTER FM
    AMA Arch Neurol Psychiatry; 1958 Aug; 80(2):148-56. PubMed ID: 13558770
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study of the transaminase activity of the cerebrospinal fluid in patients with neurological and psychiatric diseases; report on 297 cases].
    FIESCHI C; SORIANI S
    Sist Nerv; 1958; 10(6):457-74. PubMed ID: 13659100
    [No Abstract]   [Full Text] [Related]  

  • 51. GOT activity in cerebro spinal fluid in cases of cerebro-vascular accident with special reference to its prognostic significance.
    Kohli RK; Shrivastava MP; Bahl AN; Sikand PC
    J Assoc Physicians India; 1978 Jun; 26(6):485-9. PubMed ID: 721749
    [No Abstract]   [Full Text] [Related]  

  • 52. [The so-called paralysis curve of the goldsol reaction in nonsyphiliic neuropathies].
    Grahmann H
    Nervenarzt; 1969 Feb; 40(2):92-5. PubMed ID: 4312052
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
    Johannsson B; Roos BE
    Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
    [No Abstract]   [Full Text] [Related]  

  • 54. [Penetration of 99mTcO4- into cerebrospinal fluid from blood on brain scintigraphy (author's transl)].
    Takeyama E; Ookubo T; Baba M; Beppu T; Kitamura K
    No Shinkei Geka; 1975 May; 3(5):389-97. PubMed ID: 1239680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study of transaminase in the cerebrospinal fluid of patients with neuroectodermal tumors of the brain].
    Murzaliev A
    Sov Zdravookhr Kirg; 1965; 2():3-7. PubMed ID: 5840208
    [No Abstract]   [Full Text] [Related]  

  • 56. Cerebrospinal fluid glutamic oxalacetic transaminase activity in neurologic disease.
    GREEN JB; OLDEWURTEL HA; O'DOHERTY DS; FORSTER FM; SANCHEZ-LONGO LP
    Neurology; 1957 May; 7(5):313-22. PubMed ID: 13418972
    [No Abstract]   [Full Text] [Related]  

  • 57. [Transaminase activity of cerebrospinal fluid in various diseases of the central nervous system].
    YANG YM; CHENG ST; CHEN JS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1961; 2():132-40. PubMed ID: 14008976
    [No Abstract]   [Full Text] [Related]  

  • 58. Glutamic oxalacetic transaminase in the cerebrospinal fluid of man.
    SEVELA M
    Experientia; 1957 Jul; 13(7):295-6. PubMed ID: 13461862
    [No Abstract]   [Full Text] [Related]  

  • 59. Glutamic oxalacetic transaminase in cerebrospinal fluid.
    MIYAZAKI M
    J Nerv Ment Dis; 1958 Feb; 126(2):169-75. PubMed ID: 13525966
    [No Abstract]   [Full Text] [Related]  

  • 60. The spinal fluid proteins in cerebrovascular disease.
    BRONSKY D; KAPLITZ SE; ADE RD; DUBIN A
    Am J Med Sci; 1962 Jul; 244():54-8. PubMed ID: 13873424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.